Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The person must have signed an informed consent form at the time of joining the study.
- The person must be between 30 and 70 years old.
- The person must have been diagnosed with Type 2 diabetes (according to American Diabetes Association standards) for at least 6 months.
- The person must have stable blood sugar control, shown by a specific blood test result (HbA1c) below 7.5% on two separate measurements before joining the study.
- The person must have had a body mass index (BMI) of 30 or higher during the 3 months before being assigned to a treatment group.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who regularly take corticosteroids (a type of anti-inflammatory medication) or non-steroidal anti-inflammatory drugs (such as ibuprofen) three or more times per week on an ongoing basis, as these medications can affect the body's inflammation levels.
- People who have a clear medical need for two antiplatelet medications at the same time (such as blood-thinning treatments) or who are on a full-dose anticoagulant (blood-thinning) therapy.
- People who currently have cancer, or who have been in full remission from cancer for less than one year — though certain early-stage treated skin cancers may be an exception (confirm with trial site).
- Women who are able to become pregnant and are currently pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dario Pitocco, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +39 0630154071
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Body Weight
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.